Biological Hemostatic Material - Global and China Top Players Market Share and Ranking 2023
Biological Hemostatic Material - Global and China Top Players Market Share and Ranking 2023
Insights into the Biological Hemostatic Material Market include supply chain optimization, Biological Hemostatic Material challenges, and growth forecasts segmented by region and service type.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to latest Research, the global market for Biological Hemostatic Material should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Biological Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Biological Hemostatic Material market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Hospital grew percent to account for percent of the total market sales, and Clinic grew percent.
Biological hemostatic agents are active agents that work to provide hemostasis by activating clotting factors in the final stages of the coagulation cascade. Thrombin is activated by calcium and as noted previously acts to convert fibrinogen to fibrin, stabilizing the clot.
This report studies and analyses global Biological Hemostatic Material status and future trends, helps the client to determine the Biological Hemostatic Material market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Biological Hemostatic Material, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Biological Hemostatic Material market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Biological Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Biological Hemostatic Material sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Biological Hemostatic Material key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Biological Hemostatic Material key producing regions, capacity, production, and year over year growth
(6) Biological Hemostatic Material industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Johnson & Johnson
BD
Baxter
B.Braun
Cura Medical
GELITA MEDICAL
Curasan AG
Meril Life Sciences
Zhonghui Shengxi
Beijing Datsing Bio-tech
Guizhou Jin Jiu Biotech
Beijing Taikesiman
Foryou Medical
Saikesaisi Holdings Group
Biotemed
Hangzhou Singclean Medical Products
Market segment by Type, covers
Collagen
Gelatin
Polysaccharides
Other
Market segment by Application, can be divided into
Hospital
Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Biological Hemostatic Material product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Biological Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Biological Hemostatic Material market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Biological Hemostatic Material, percent & CAGR, 2018-2029
Chapter 5: Biological Hemostatic Material industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Biological Hemostatic Material Definition
1.2 Global Biological Hemostatic Material Market Size and Forecast
1.2.1 By Consumption Value, Global Biological Hemostatic Material Market Size，2018-2029
1.2.2 By Sales Quantity, Global Biological Hemostatic Material Market Size，2018-2029
1.2.3 Global Biological Hemostatic Material Average Selling Price (ASP)，2018-2029
1.3 China Biological Hemostatic Material Market Size and Forecast
1.3.1 By Consumption Value, China Biological Hemostatic Material Market Size，2018-2029
1.3.2 By Sales Quantity, China Biological Hemostatic Material Market Size，2018-2029
1.3.3 China Biological Hemostatic Material Average Selling Price (ASP)， 2018-2029
1.4 Share of China Biological Hemostatic Material Market with Respect to the Global Market
1.4.1 By Consumption Value, China Biological Hemostatic Material Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Biological Hemostatic Material Market Share in Global, 2018-2029
1.4.3 Biological Hemostatic Material Market Size: China VS Global, 2018-2029
1.5 Biological Hemostatic Material Market Dynamics
1.5.1 Biological Hemostatic Material Market Drivers
1.5.2 Biological Hemostatic Material Market Restraints
1.5.3 Biological Hemostatic Material Industry Trends
1.5.4 Biological Hemostatic Material Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Biological Hemostatic Material, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Biological Hemostatic Material, Global Market Share by Company, 2018-2023
2.3 Biological Hemostatic Material Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Biological Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Biological Hemostatic Material Concentration Ratio
2.6 Global Biological Hemostatic Material Mergers & Acquisitions, Expansion Plans
2.7 Global Biological Hemostatic Material Manufacturers Product Type
2.8 Head Office and Biological Hemostatic Material Production Site of Key Manufacturer
2.9 Biological Hemostatic Material Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Biological Hemostatic Material, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Biological Hemostatic Material, China Market Share by Company, 2018-2023
3.3 China Biological Hemostatic Material Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Biological Hemostatic Material Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Biological Hemostatic Material Capacity by Region
4.3 Global Biological Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Biological Hemostatic Material Production by Region, 2018-2029
4.5 Global Biological Hemostatic Material Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Biological Hemostatic Material Industry Chain
5.2 Biological Hemostatic Material Upstream Analysis
5.2.1 Biological Hemostatic Material Core Raw Materials
5.2.2 Main Manufacturers of Biological Hemostatic Material Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Biological Hemostatic Material Production Mode
5.6 Biological Hemostatic Material Procurement Model
5.7 Biological Hemostatic Material Industry Sales Model and Sales Channels
5.7.1 Biological Hemostatic Material Sales Model
5.7.2 Biological Hemostatic Material Typical Distributors
6 Sights by Type
6.1 Biological Hemostatic Material Classification
6.1.1 Collagen
6.1.2 Gelatin
6.1.3 Polysaccharides
6.1.4 Other
6.2 By Type, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Biological Hemostatic Material Consumption Value, 2018-2029
6.4 By Type, Global Biological Hemostatic Material Sales Quantity, 2018-2029
6.5 By Type, Global Biological Hemostatic Material Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Biological Hemostatic Material Segment by Application
7.1.1 Hospital
7.1.2 Clinic
7.1.3 Other
7.2 By Application, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Biological Hemostatic Material Consumption Value, 2018-2029
7.4 By Application, Global Biological Hemostatic Material Sales Quantity, 2018-2029
7.5 By Application, Global Biological Hemostatic Material Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Biological Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Biological Hemostatic Material Consumption Value, 2018-2029
8.3 By Region, Global Biological Hemostatic Material Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Biological Hemostatic Material & Forecasts, 2018-2029
8.4.2 By Country, North America Biological Hemostatic Material Market Size Market Share
8.5 Europe
8.5.1 Europe Biological Hemostatic Material Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Biological Hemostatic Material Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Biological Hemostatic Material Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Biological Hemostatic Material Market Size Market Share
8.7 South America
8.7.1 South America Biological Hemostatic Material Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Biological Hemostatic Material Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Biological Hemostatic Material Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Biological Hemostatic Material Consumption Value, 2018-2029
9.3 By Country, Global Biological Hemostatic Material Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Biological Hemostatic Material Market Size, 2018-2029
9.4.2 By Type, U.S. Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Biological Hemostatic Material Market Size, 2018-2029
9.5.2 By Type, Europe Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Biological Hemostatic Material Market Size, 2018-2029
9.6.2 By Type, China Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Biological Hemostatic Material Market Size, 2018-2029
9.7.2 By Type, Japan Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Biological Hemostatic Material Market Size, 2018-2029
9.8.2 By Type, South Korea Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Biological Hemostatic Material Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Biological Hemostatic Material Market Size, 2018-2029
9.10.2 By Type, India Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Biological Hemostatic Material Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Biological Hemostatic Material Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.1.2 Johnson & Johnson Biological Hemostatic Material Models, Specifications, and Application
10.1.3 Johnson & Johnson Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Johnson & Johnson Company Profile and Main Business
10.1.5 Johnson & Johnson Recent Developments
10.2 BD
10.2.1 BD Company Information, Head Office, Market Area, and Industry Position
10.2.2 BD Biological Hemostatic Material Models, Specifications, and Application
10.2.3 BD Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 BD Company Profile and Main Business
10.2.5 BD Recent Developments
10.3 Baxter
10.3.1 Baxter Company Information, Head Office, Market Area, and Industry Position
10.3.2 Baxter Biological Hemostatic Material Models, Specifications, and Application
10.3.3 Baxter Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Baxter Company Profile and Main Business
10.3.5 Baxter Recent Developments
10.4 B.Braun
10.4.1 B.Braun Company Information, Head Office, Market Area, and Industry Position
10.4.2 B.Braun Biological Hemostatic Material Models, Specifications, and Application
10.4.3 B.Braun Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 B.Braun Company Profile and Main Business
10.4.5 B.Braun Recent Developments
10.5 Cura Medical
10.5.1 Cura Medical Company Information, Head Office, Market Area, and Industry Position
10.5.2 Cura Medical Biological Hemostatic Material Models, Specifications, and Application
10.5.3 Cura Medical Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Cura Medical Company Profile and Main Business
10.5.5 Cura Medical Recent Developments
10.6 GELITA MEDICAL
10.6.1 GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position
10.6.2 GELITA MEDICAL Biological Hemostatic Material Models, Specifications, and Application
10.6.3 GELITA MEDICAL Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 GELITA MEDICAL Company Profile and Main Business
10.6.5 GELITA MEDICAL Recent Developments
10.7 Curasan AG
10.7.1 Curasan AG Company Information, Head Office, Market Area, and Industry Position
10.7.2 Curasan AG Biological Hemostatic Material Models, Specifications, and Application
10.7.3 Curasan AG Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Curasan AG Company Profile and Main Business
10.7.5 Curasan AG Recent Developments
10.8 Meril Life Sciences
10.8.1 Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
10.8.2 Meril Life Sciences Biological Hemostatic Material Models, Specifications, and Application
10.8.3 Meril Life Sciences Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Meril Life Sciences Company Profile and Main Business
10.8.5 Meril Life Sciences Recent Developments
10.9 Zhonghui Shengxi
10.9.1 Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position
10.9.2 Zhonghui Shengxi Biological Hemostatic Material Models, Specifications, and Application
10.9.3 Zhonghui Shengxi Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Zhonghui Shengxi Company Profile and Main Business
10.9.5 Zhonghui Shengxi Recent Developments
10.10 Beijing Datsing Bio-tech
10.10.1 Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position
10.10.2 Beijing Datsing Bio-tech Biological Hemostatic Material Models, Specifications, and Application
10.10.3 Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Beijing Datsing Bio-tech Company Profile and Main Business
10.10.5 Beijing Datsing Bio-tech Recent Developments
10.11 Guizhou Jin Jiu Biotech
10.11.1 Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position
10.11.2 Guizhou Jin Jiu Biotech Biological Hemostatic Material Models, Specifications, and Application
10.11.3 Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Guizhou Jin Jiu Biotech Company Profile and Main Business
10.11.5 Guizhou Jin Jiu Biotech Recent Developments
10.12 Beijing Taikesiman
10.12.1 Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position
10.12.2 Beijing Taikesiman Biological Hemostatic Material Models, Specifications, and Application
10.12.3 Beijing Taikesiman Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Beijing Taikesiman Company Profile and Main Business
10.12.5 Beijing Taikesiman Recent Developments
10.13 Foryou Medical
10.13.1 Foryou Medical Company Information, Head Office, Market Area, and Industry Position
10.13.2 Foryou Medical Biological Hemostatic Material Models, Specifications, and Application
10.13.3 Foryou Medical Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Foryou Medical Company Profile and Main Business
10.13.5 Foryou Medical Recent Developments
10.14 Saikesaisi Holdings Group
10.14.1 Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position
10.14.2 Saikesaisi Holdings Group Biological Hemostatic Material Models, Specifications, and Application
10.14.3 Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Saikesaisi Holdings Group Company Profile and Main Business
10.14.5 Saikesaisi Holdings Group Recent Developments
10.15 Biotemed
10.15.1 Biotemed Company Information, Head Office, Market Area, and Industry Position
10.15.2 Biotemed Biological Hemostatic Material Models, Specifications, and Application
10.15.3 Biotemed Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.15.4 Biotemed Company Profile and Main Business
10.15.5 Biotemed Recent Developments
10.16 Hangzhou Singclean Medical Products
10.16.1 Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position
10.16.2 Hangzhou Singclean Medical Products Biological Hemostatic Material Models, Specifications, and Application
10.16.3 Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.16.4 Hangzhou Singclean Medical Products Company Profile and Main Business
10.16.5 Hangzhou Singclean Medical Products Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Biological Hemostatic Material Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Biological Hemostatic Material Market Restraints
Table 3. Biological Hemostatic Material Market Trends
Table 4. Biological Hemostatic Material Industry Policy
Table 5. Global Biological Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Biological Hemostatic Material Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Biological Hemostatic Material Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Biological Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Biological Hemostatic Material Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Biological Hemostatic Material Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Biological Hemostatic Material Mergers & Acquisitions, Expansion Plans
Table 12. Global Biological Hemostatic Material Manufacturers Product Type
Table 13. Head Office and Biological Hemostatic Material Production Site of Key Manufacturer
Table 14. Biological Hemostatic Material Capacity of Major Manufacturers and Future Plan
Table 15. China Biological Hemostatic Material Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Biological Hemostatic Material Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Biological Hemostatic Material Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Biological Hemostatic Material Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Biological Hemostatic Material Production by Region, 2018-2023, (K Units)
Table 20. Global Biological Hemostatic Material Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Biological Hemostatic Material Upstream (Raw Materials)
Table 22. Global Biological Hemostatic Material Typical Customers
Table 23. Biological Hemostatic Material Typical Distributors
Table 24. By Type, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Biological Hemostatic Material Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Biological Hemostatic Material Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Biological Hemostatic Material Sales Quantity Market Share, 2018-2029
Table 34. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
Table 35. Johnson & Johnson Biological Hemostatic Material Models, Specifications, and Application
Table 36. Johnson & Johnson Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Johnson & Johnson Company Profile and Main Business
Table 38. Johnson & Johnson Recent Developments
Table 39. BD Company Information, Head Office, Market Area, and Industry Position
Table 40. BD Biological Hemostatic Material Models, Specifications, and Application
Table 41. BD Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. BD Company Profile and Main Business
Table 43. BD Recent Developments
Table 44. Baxter Company Information, Head Office, Market Area, and Industry Position
Table 45. Baxter Biological Hemostatic Material Models, Specifications, and Application
Table 46. Baxter Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Baxter Company Profile and Main Business
Table 48. Baxter Recent Developments
Table 49. B.Braun Company Information, Head Office, Market Area, and Industry Position
Table 50. B.Braun Biological Hemostatic Material Models, Specifications, and Application
Table 51. B.Braun Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. B.Braun Company Profile and Main Business
Table 53. B.Braun Recent Developments
Table 54. Cura Medical Company Information, Head Office, Market Area, and Industry Position
Table 55. Cura Medical Biological Hemostatic Material Models, Specifications, and Application
Table 56. Cura Medical Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Cura Medical Company Profile and Main Business
Table 58. Cura Medical Recent Developments
Table 59. GELITA MEDICAL Company Information, Head Office, Market Area, and Industry Position
Table 60. GELITA MEDICAL Biological Hemostatic Material Models, Specifications, and Application
Table 61. GELITA MEDICAL Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. GELITA MEDICAL Company Profile and Main Business
Table 63. GELITA MEDICAL Recent Developments
Table 64. Curasan AG Company Information, Head Office, Market Area, and Industry Position
Table 65. Curasan AG Biological Hemostatic Material Models, Specifications, and Application
Table 66. Curasan AG Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Curasan AG Company Profile and Main Business
Table 68. Curasan AG Recent Developments
Table 69. Meril Life Sciences Company Information, Head Office, Market Area, and Industry Position
Table 70. Meril Life Sciences Biological Hemostatic Material Models, Specifications, and Application
Table 71. Meril Life Sciences Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Meril Life Sciences Company Profile and Main Business
Table 73. Meril Life Sciences Recent Developments
Table 74. Zhonghui Shengxi Company Information, Head Office, Market Area, and Industry Position
Table 75. Zhonghui Shengxi Biological Hemostatic Material Models, Specifications, and Application
Table 76. Zhonghui Shengxi Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Zhonghui Shengxi Company Profile and Main Business
Table 78. Zhonghui Shengxi Recent Developments
Table 79. Beijing Datsing Bio-tech Company Information, Head Office, Market Area, and Industry Position
Table 80. Beijing Datsing Bio-tech Biological Hemostatic Material Models, Specifications, and Application
Table 81. Beijing Datsing Bio-tech Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Beijing Datsing Bio-tech Company Profile and Main Business
Table 83. Beijing Datsing Bio-tech Recent Developments
Table 84. Guizhou Jin Jiu Biotech Company Information, Head Office, Market Area, and Industry Position
Table 85. Guizhou Jin Jiu Biotech Biological Hemostatic Material Models, Specifications, and Application
Table 86. Guizhou Jin Jiu Biotech Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Guizhou Jin Jiu Biotech Company Profile and Main Business
Table 88. Guizhou Jin Jiu Biotech Recent Developments
Table 89. Beijing Taikesiman Company Information, Head Office, Market Area, and Industry Position
Table 90. Beijing Taikesiman Biological Hemostatic Material Models, Specifications, and Application
Table 91. Beijing Taikesiman Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Beijing Taikesiman Company Profile and Main Business
Table 93. Beijing Taikesiman Recent Developments
Table 94. Foryou Medical Company Information, Head Office, Market Area, and Industry Position
Table 95. Foryou Medical Biological Hemostatic Material Models, Specifications, and Application
Table 96. Foryou Medical Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Foryou Medical Company Profile and Main Business
Table 98. Foryou Medical Recent Developments
Table 99. Saikesaisi Holdings Group Company Information, Head Office, Market Area, and Industry Position
Table 100. Saikesaisi Holdings Group Biological Hemostatic Material Models, Specifications, and Application
Table 101. Saikesaisi Holdings Group Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Saikesaisi Holdings Group Company Profile and Main Business
Table 103. Saikesaisi Holdings Group Recent Developments
Table 104. Biotemed Company Information, Head Office, Market Area, and Industry Position
Table 105. Biotemed Biological Hemostatic Material Models, Specifications, and Application
Table 106. Biotemed Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Biotemed Company Profile and Main Business
Table 108. Biotemed Recent Developments
Table 109. Hangzhou Singclean Medical Products Company Information, Head Office, Market Area, and Industry Position
Table 110. Hangzhou Singclean Medical Products Biological Hemostatic Material Models, Specifications, and Application
Table 111. Hangzhou Singclean Medical Products Biological Hemostatic Material Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 112. Hangzhou Singclean Medical Products Company Profile and Main Business
Table 113. Hangzhou Singclean Medical Products Recent Developments
List of Figures
Figure 1. Biological Hemostatic Material Picture
Figure 2. Global Biological Hemostatic Material Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Biological Hemostatic Material Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Biological Hemostatic Material Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Biological Hemostatic Material Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Biological Hemostatic Material Sales Quantity (K Units) & (2018-2029)
Figure 7. China Biological Hemostatic Material Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Biological Hemostatic Material Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Biological Hemostatic Material Market Share of Global, 2018-2029
Figure 10. Global Biological Hemostatic Material Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Biological Hemostatic Material Key Participants, Market Share, 2022
Figure 12. Global Biological Hemostatic Material Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Biological Hemostatic Material Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Biological Hemostatic Material Production Market Share & Forecast by Region, 2018-2029
Figure 15. Biological Hemostatic Material Industry Chain
Figure 16. Biological Hemostatic Material Procurement Model
Figure 17. Biological Hemostatic Material Sales Model
Figure 18. Biological Hemostatic Material Sales Channels, Direct Sales, and Distribution
Figure 19. Collagen
Figure 20. Gelatin
Figure 21. Polysaccharides
Figure 22. Other
Figure 23. By Type, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million
Figure 24. By Type, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029
Figure 25. By Type, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K Units)
Figure 26. By Type, Global Biological Hemostatic Material Sales Quantity Market Share, 2018-2029
Figure 27. By Type, Global Biological Hemostatic Material Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 28. Hospital
Figure 29. Clinic
Figure 30. Other
Figure 31. By Application, Global Biological Hemostatic Material Consumption Value, 2018-2029, US$ Million
Figure 32. By Application, Global Biological Hemostatic Material Consumption Value Market Share, 2018-2029
Figure 33. By Application, Global Biological Hemostatic Material Sales Quantity, 2018-2029, (K
Research Methodology:
Biological Hemostatic Material Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|